Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol.

Susan C. Nagel(University of Missouri Health System), Wade V. Welshons(Missouri College), Kristina A. Thayer(United States Department of Health and Human Services), Michael Boechler(Tripler Army Medical Center), Minati Dhar(University of Missouri), Frederick S. vom Saal(University of Atlanta)
Environmental Health Perspectives
January 1, 1997
Cited by 775


Related Papers